Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Showcase Its Boutique End-to-End CDMO Services at the Premier CPHI Barcelona Event

Scinai Immunotherapeutics (NASDAQ: SCNI), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products, will be showcasing its Contract Development and Manufacturing Organization (“CDMO”) services at CPHI Barcelona, a premier three-day event that brings together pharmaceutical professionals, industry leaders, and businesses to advance human health. The event is scheduled for October 24 to […]

DGE 4th Next Generation MSL Excellence Summit 2023: Navigating Thought Leader Engagement in the Digital Age

DGE’S 4th Next Generation MSL Excellence Summit will be held on November 13-14, 2023 in Philadelphia, along with a live streaming option. The event revolves around offering lucrative thought leader engagement strategies to MSLs and field executives along with data, tools, and tips to engage with their audiences. As remote meetings have become the preferred […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Two New Canadian Patents Amid Continued Efforts to Safeguard the Applicability of Its DehydraTECH(TM) Technology in Multiple Jurisdictions and Sectors

Lexaria Bioscience (NASDAQ: LEXX) is a global innovator and biotechnology company focused on developing technology that enhances the bioavailability of multiple fat-soluble active molecules and active pharmaceutical ingredients (“APIs”). The company’s flagship technology is the patented DehydraTECH(TM) drug delivery technology, which combines fat-soluble (lipophilic) molecules or APIs with specific fatty acids and carrier compounds, improving […]

DGE 3rd Investigator Initiated Trials Summit 2023: Unlocking Innovations in Pharma Research and Collaboration

The 3rd Investigator Initiated Trials Summit will be held on November 13-14, 2023 in Philadelphia. The DGE event is focused on exploring the most lucrative ways for reviewing, selecting, and funding research investigators. Researchers, medical officers, health and pharma executives and companies can harness the reach and network of the DGE platform to connect with […]

Clene Inc. (NASDAQ: CLNN) Announces Four-Year Grant to Support Expanded Access Protocol for CNM-Au8 From NINDS

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company on a mission to transform the treatment of neurodegenerative diseases, recently announced that its wholly-owned subsidiary Clene Nanomedicine Inc., in collaboration with Columbia University and Synapticure, has been awarded a four-year grant totaling $45.1 million from the National Institute of Neurological Disorders and Stroke (“NINDS”). The grant […]

Electronic Servitor Publication Network Inc.’s (XESP) Focused Approach to Creating Profitable Customer Interactions

Electronic Servitor Publication Network (OTCQB: XESP), a market disruptor for B2B companies using cutting-edge data analysis and smart technology, is staying ahead of the curve, leveraging new and more efficient ways for businesses to drive engagement, reach bigger audiences, and build authority and credibility in their spaces. Its approach has earned it recognition from growth-focused […]

Prospera Energy Inc. (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B) Provides Update on Drill Program; Announces Low-Dilutive Capital Raise

Prospera Energy (TSX.V: PEI) (OTC: GXRFF) (FRA: OF6B), a public oil and gas exploration, exploitation and development company focusing on conventional oil and gas reservoirs in Western Canada, recently provided the market with an update on the second phase of its restructuring program. Boasting a business model centered around optimizing hydrocarbon recovery from legacy fields […]

Unlocking Social Media Success: Insights, Strategies, and Networking at the 2023 Social Media Strategies Summit for Senior Marketing Professionals

Social media marketers, businesses, company executives, influencers and marketing heads, are invited to attend the Social Media Strategies Summit for Senior Level Marketing Professionals, October 26-27, 2023. This two-day virtual event will be attended by social media stalwarts who will share their time-tested strategies for conducting successful social media campaigns for organizations. The event will […]

Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) Reports Positive Initial Assays from Brazilian REE Drill Project

Mineral explorer Appia Rare Earths & Uranium (CSE: API) (OTCQX: APAAF) is making significant progress in its Brazilian rare earth reverse circulation (“RC”) drilling campaign, reporting overall weighted average grades of total rare earth oxides (“TREOs”) that are comparable or superior to other well-known international deposits. In an Oct. 16 news release, the Company stated […]

 

From Our Blog

Beeline Holdings, Inc. (NASDAQ: BLNE) CEO Details 2025 Milestones and Strategic Priorities

January 20, 2026

Beeline Holdings (NASDAQ: BLNE),  a rapidly growing digital mortgage platform streamlining the path to homeownership, presented a series of operational and financial milestones from 2025 while setting out the company’s strategic priorities for the year ahead, according to a shareholder letter published by CEO Nick Liuzza on January 15, 2026. The letter provides investors with […]

Rotate your device 90° to view site.